PREFERENCES FOR ADJUVANT CHEMOTHERAPY IN AN ANZGOG SUBSTUDY OF THE PORTEC-3 INTERGROUP RANDOMIZED CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY IN HIGH RISK ENDOMETRIAL CANCER

Author(s):
Blinman, P.; Mileshkin, L.; Khaw, P.; Goss, G.; Johnson, C.; Capp, A.; Brooks, S.; Wain, G.; Kolodzeij, I.; Veillard, A.S.; Creutzberg, C.; Stockler, M.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-11-30
Language
English
Is part of
hdl
1887/104621